5117.0 Public Interests & the Pharmaceutical Industry

Wednesday, October 29, 2008: 10:30 AM
Panel Discussion
Organizer:
Maggie Huff-Rousselle, MA, MBA, PhD
Moderator:
Maggie Huff-Rousselle, MA, MBA, PhD

10:30 AM
Consolidating Pharmaceutical Purchasing Across National Boundaries: A Pragmatic Role for Our Public Institutions?
Maggie Huff-Rousselle, MA, MBA, PhD
     
10:48 AM
Procurement in the public interest: Efforts to increase transparency and accountability for ARV drug supplies
Brenda Waning and Taryn Vian, MSc
11:06 AM
Pharma confronts the 21st century: Generic competition, compulsory licensing, and drug access and safety challenges from abroad
Jack Warren Salmon, PhD and Meghana Aruru, PhD (cand)
     
11:24 AM
Compulsory Licensing: Effecting access to medicines in the developing world?
Meghana Aruru, PhD (cand) and Jack Warren Salmon, PhD
     
11:42 AM
Updates in the marketing of infant formula in the US: Ongoing conflicts of the pharmaceutical industry and the public interest
Melissa C. Bartick, MD, MS, Marsha Walker, RN, IBCLC and Anne Merewood, PhD, MPH, IBCLC
     

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: International Health
Endorsed by: Ethics SPIG, Medical Care, Trade & Health Forum

See more of: International Health
<< Previous Session | Next Session >>